Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Marinus Pharma CS (MRNS)

Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Author
3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity MarketBeat - Fri Oct 11, 8:28AM CDT

Check out these three micro-cap stocks that show big-time potential upside, but also pose face large obstacles to achieving success.

IWC : 135.25 (+0.22%)
LODE : 0.3788 (+2.38%)
AMPX : 1.2900 (+2.38%)
SPY : 595.94 (+0.83%)
MRNS : 0.3601 (+7.52%)
Author
Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech? MarketBeat - Tue Oct 1, 9:48AM CDT

Marinus is an under $2 biotech stock with Wall Street analysts price targets ranging from $2 to $13. Its upcoming trial results have big implications.

MRNS : 0.3601 (+7.52%)
Marinus Pharmaceuticals: Q2 Earnings Snapshot AP - Tue Aug 13, 6:07AM CDT

Marinus Pharmaceuticals: Q2 Earnings Snapshot

MRNS : 0.3601 (+7.52%)
Marinus Pharmaceuticals: Q1 Earnings Snapshot AP - Wed May 8, 6:29AM CDT

Marinus Pharmaceuticals: Q1 Earnings Snapshot

MRNS : 0.3601 (+7.52%)
Marinus Pharmaceuticals: Q4 Earnings Snapshot AP - Tue Mar 5, 3:24PM CST

Marinus Pharmaceuticals: Q4 Earnings Snapshot

MRNS : 0.3601 (+7.52%)
Marinus Pharmaceuticals: Q2 Earnings Snapshot AP - Thu Aug 10, 2023

Marinus Pharmaceuticals: Q2 Earnings Snapshot

MRNS : 0.3601 (+7.52%)
Marinus Pharmaceuticals: Q1 Earnings Snapshot AP - Thu May 11, 2023

Marinus Pharmaceuticals: Q1 Earnings Snapshot

MRNS : 0.3601 (+7.52%)
Marinus Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire - Wed May 3, 2023

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will present...

MRNS : 0.3601 (+7.52%)
Marinus Pharmaceuticals to Provide Business Update and Report First Quarter 2023 Financial Results on May 11, 2023 Business Wire - Thu Apr 27, 2023

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it plans to release financial...

MRNS : 0.3601 (+7.52%)

Barchart Exclusives

Can the REMX ETF Rally? Barchart - 35 minutes ago
While the REMX ETF’s name implies significant exposure to rare earth metals and minerals, the product’s holdings are primarily invested in lithium-producing mining companies. REMX has been under pressure, but commodity cyclicality suggests that it is in the buying zone below $50 per share. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot